The Risk Of Dangerous Blood Clots And Strokes.
A green anti-clotting cure to slim the risk of dangerous blood clots and strokes in settle with a type of heart rhythm disorder has been approved by the US Food and Drug Administration. Savaysa (edoxaban) is approved to to woman in the street with atrial fibrillation that's not caused by a heart valve problem muscle. Atrial fibrillation - the most usual type of love rhythm disorder - increases the risk of developing blood clots that can tour to the brain and cause a stroke.
Savaysa pills are also approved to act toward deep vein thrombosis and pulmonary embolism in man already treated with an injected or infused anti-clotting drug for five to 10 days, according to the FDA. Deep streak thrombosis is a blood clot that forms in a wide vein, usually in the lower stretch or thigh. Pulmonary embolism is a potentially deadly condition that occurs when a rich vein blood clot breaks off and travels to an artery in the lungs, blocking blood flow.
